US Broker Ratings

BioLife Solutions, Inc. (BLFS) Investor Outlook: Capitalizing on a 27.76% Potential Upside in the Booming Healthcare Sector

BioLife Solutions, Inc. (BLFS), a prominent player in the healthcare sector specializing in medical instruments and supplies, is garnering significant investor attention. With its market capitalization standing at $1.17 billion,..

Premier, Inc. (PINC): Investor Outlook Amidst Mixed Analyst Ratings and a Solid Dividend Yield

Premier, Inc. (NASDAQ: PINC), a prominent player in the healthcare improvement sector, offers a fascinating case for investors amid a challenging market environment. With a market capitalization of $2.01 billion,..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: A Potential 7.53% Upside in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is gaining attention in the healthcare sector, particularly among investors eyeing the drug manufacturers – specialty and generic industry. With a focus on developing and..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Is a 43% Upside Too Good to Ignore?

For investors scouting the healthcare sector for promising opportunities, Establishment Labs Holdings Inc (NASDAQ: ESTA) presents an intriguing case. Specializing in medical devices within the realm of aesthetic and reconstructive..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 67% Upside Potential

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a compelling opportunity for investors with a notable potential upside of 67.09%...

UFP Technologies (UFPT) Stock Analysis: Exploring a 50% Upside Potential in Medical Device Market

UFP Technologies, Inc. (UFPT), a notable player in the medical devices industry, has positioned itself as a formidable force in the healthcare sector with its innovative solutions for medical devices..

Kestra Medical Technologies (KMTS): Investor Outlook Reveals a Promising 66.77% Upside Potential

Investors searching for opportunities in the healthcare sector may find Kestra Medical Technologies, Ltd. (KMTS) an appealing candidate. This Kirkland, Washington-based company is carving out a niche in the medical..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Unveiling a 10.25% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With its headquarters in Burlington, Massachusetts, LeMaitre Vascular..

Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook with a 38.82% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) has garnered significant attention in the healthcare sector, particularly within the biotechnology industry. With a current market capitalization of $2.09 billion, this U.S.-based company..

Opko Health, Inc. (OPK) Stock Analysis: Exploring the 158.93% Upside Potential for Investors

Opko Health, Inc. (NASDAQ: OPK), a dynamic player in the healthcare sector, offers promising opportunities for investors looking for potential growth in the diagnostics and pharmaceuticals industries. Headquartered in Miami,..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Innovator with 106% Potential Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company headquartered in Singapore, is gaining traction among investors due to its innovative RNA medicines platform, PRISM, and the significant potential..

Indivior PLC (INDV) Stock Analysis: Exploring a 16.71% Upside Potential with Strong Buy Ratings

Indivior PLC (NASDAQ: INDV), a key player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, has captured investor attention with its recent stock performance and..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Exploring a Potential 99.61% Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) stands out in the healthcare sector, particularly within the drug manufacturers’ niche focused on specialty and generic medications. With a market capitalization of $1.76 billion,..

agilon health, inc. (AGL) Stock Analysis: Evaluating the 41% Potential Upside Amid Market Challenges

As an intriguing player in the healthcare sector, agilon health, inc. (NYSE: AGL) has caught the attention of investors with its innovative approach to senior healthcare services. Despite facing some..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Navigating Growth with a 4.84% Upside Potential

GoodRx Holdings, Inc. (NASDAQ: GDRX), a prominent player in the health information services industry, offers a unique platform enabling consumers to compare and save on prescription drug purchases across the..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a Potential 108% Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is currently a focal point within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $732.45 million, this U.S.-based..

Certara, Inc. (CERT) Stock Analysis: Unveiling a 26% Potential Upside in Healthcare Technology

Certara, Inc. (NASDAQ: CERT) stands at the intersection of healthcare and technology, offering a compelling investment opportunity with a potential upside of over 26%, as suggested by current analyst ratings...

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: High Revenue Growth and Analyst Confidence Signal Potential Upside

Investors looking at ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) may find themselves intrigued by the impressive revenue growth and the bullish sentiment from analysts that hint at a potential upside in..

Addus HomeCare Corporation (ADUS) Stock Analysis: A 21% Upside Potential in the Booming Healthcare Sector

Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the healthcare sector, has captured investor attention with its robust outlook and significant growth potential. Specializing in personal care services for..

Evotec SE (EVO) Stock Analysis: A 56% Upside Potential Amidst Strategic Collaborations

Evotec SE (EVO), a prominent player in the healthcare sector, operates as a drug discovery and development company with a significant presence in the United States, Germany, France, the United..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds